

Instance: composition-en-49f2652f369e152b2094223d335e67b9
InstanceOf: CompositionUvEpi
Title: "Composition for xofluza Package Leaflet"
Description:  "Composition for xofluza Package Leaflet"
Usage: #example

* identifier.system = ""

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mock)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - xofluza"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet </p>
<ol>
<li>What Xofluza is and what it is used for  </li>
<li>What you need to know before you take Xofluza </li>
<li>How to take Xofluza </li>
<li>Possible side effects  </li>
<li>How to store Xofluza </li>
<li>Contents of the pack and other information </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What xofluza is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What xofluza is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Xofluza is </p>
<p>Xofluza contains baloxavir marboxil. This is a type of antiviral medicine called a  cap-dependent 
endonuclease inhibitor .  </p>
<p>Xofluza is used for treating and preventing influenza. This medicine stops the influenza virus from 
spreading in the body and helps shorten the time to recovery from symptoms.  </p>
<p>What Xofluza is used for </p>
<ul>
<li>Xofluza is used to treat influenza in patients aged 1 year and above who have had influenza 
symptoms for less than 48 hours. </li>
<li>Xofluza is used to prevent influenza in individuals aged 1 year and above who have been in 
close contact with someone who is known or suspected to have influenza. </li>
</ul>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take xofluza"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take xofluza"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not take Xofluza if: </p>
<ul>
<li>you are allergic to baloxavir marboxil or any of the other ingredients of this medicine (listed in 
section 6). </li>
</ul>
<p>Warnings and precautions  </p>
<p>Talk to your doctor or pharmacist before taking Xofluza. 
Infants and Children  </p>
<p>Do not give this medicine to children below 1 year of age. This is because the effects of Xofluza in 
this age group are not known.  </p>
<p>Other medicines and Xofluza </p>
<p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other 
medicines.  </p>
<p>Do not take Xofluza with:<br />
* laxatives, antacids or oral supplements containing iron, zinc, selenium, calcium, or magnesium </p>
<p>The medicines listed above may decrease the effect of Xofluza.  </p>
<p>Pregnancy and breast-feeding </p>
<p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, as a 
precautionary measure it is preferable to avoid the use of Xofluza. Ask your doctor or pharmacist for 
advice before taking this medicine. </p>
<p>Driving and using machines </p>
<p>Xofluza is not likely to change your ability to drive and to use machines. </p>
<p>Xofluza contains lactose </p>
<p>Xofluza contains lactose (a type of sugar). If you have been told by your doctor that you have an 
intolerance to some sugars, talk to your doctor before taking this medicine. </p>
<p>Xofluza contains sodium </p>
<p>This medicine contains less than 23 mg of sodium per tablet, that is to say essentially  sodium-free . </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take xofluza"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take xofluza"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor 
or pharmacist if you are not sure. </p>
<p>When to take Xofluza </p>
<p>For treatment of influenza, take Xofluza as a single dose as soon as possible within 48 hours of your 
flu symptoms starting. </p>
<p>For prevention of influenza, take Xofluza as a single dose as soon as possible within 48 hours 
following exposure to an infected person. </p>
<p>How much Xofluza to take </p>
<p>Your dose of Xofluza depends on how much you weigh. Your doctor or pharmacist will tell you how 
much to take. </p>
<p>Your weight </p>
<p>Xofluza dose 
&lt; 20 kg 
Refer to the Xofluza granules for oral suspension package 
leaflet 
. 
  20 kg - &lt; 80 kg 
Single dose of 40 mg taken as 
- 2 x 20 mg tablets </p>
<p>80 kg or more </p>
<p>Single dose of 80 mg taken as<br />
- 2 x 40 mg tablets </p>
<p>Xofluza can be taken with or without food. Take all the tablets with some water.  </p>
<p>If you take more Xofluza than you should </p>
<p>If you accidentally take more of this medicine than you should, talk to your doctor or pharmacist for 
advice. </p>
<p>If you forget to take Xofluza </p>
<p>If you forget to take some or all of your dose, take it as soon as possible.  </p>
<p>For the treatment of influenza, Xofluza should be taken within 48 hours of your flu symptoms starting. </p>
<p>For the prevention of influenza, Xofluza should be taken within 48 hours of close contact with 
someone who is known or suspected to have flu. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, it is possible for this medicine to cause side effects, although not everybody gets 
them. </p>
<p>Adults, adolescents and children </p>
<p>Get medical help immediately if you get any of the following serious side effects: 
* Severe allergic reaction (anaphylaxis), with signs such as swelling of the face or skin, itchy 
rashes, low blood pressure and difficulty breathing </p>
<p>The frequency of these side effects cannot be estimated from the available data. </p>
<p>Other possible side effects: 
The following side effect is uncommon (this can affect up to 1 in every 100 patients): 
* Itchy rash </p>
<p>Children (1 to &lt;12 years) 
The following side effects are common (this can affect up to 1 in every 10 patients)<br />
* Diarrhoea, rash and vomiting </p>
<p>Reporting of side effects </p>
<p>If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this 
leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. 
By reporting side effects you can help provide more information on the safety of this medicine. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store xofluza"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store xofluza"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. </p>
<p>Do not use this medicine after the expiry date which is stated on the blister and carton after  EXP . 
The expiry date refers to the last day of that month. </p>
<p>This medicine does not need any special temperature storage conditions. </p>
<p>Store in the original package in order to protect from moisture. 
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to 
throw away medicines you no longer use. These measures will help protect the environment. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Xofluza contains  </p>
<ul>
<li>The active substance is baloxavir marboxil.  </li>
<li>Each 20 mg film-coated tablet contains 20 mg baloxavir marboxil. Each 40 mg film-coated 
tablet contains 40 mg baloxavir marboxil. </li>
<li>The other ingredients are lactose monohydrate (see Section 2  Xofluza contains lactose ), 
croscarmellose sodium ((E468) (see Section 2  Xofluza contains sodium )), povidone (K25) 
(E1201), microcrystalline cellulose (E460), sodium stearyl fumarate in the tablet core, and 
hypromellose (E464), talc (E553b) and titanium dioxide (E171) in the film-coating. </li>
</ul>
<p>What Xofluza looks like and contents of the pack </p>
<p>Xofluza 20 mg tablets are white to light yellow, oblong shaped film-coated tablets with<br />
 772<br />
marked on one side and  20  on the other side. </p>
<p>Xofluza 20 mg film-coated tablets are available in blister packs of 2. Xofluza 40 mg tablets are white to light yellow, oblong shaped film-coated tablets with  BXM40<br />
marked on one side.  </p>
<p>Xofluza 40 mg film-coated tablets are available in blister packs of 2. Marketing Authorisation Holder </p>
<p>Roche Registration GmbH 
Emil-Barell-Strasse 1 
79639 Grenzach-Wyhlen 
Germany </p>
<p>Manufacturer </p>
<p>Roche Pharma AG 
Emil-Barell-Strasse 1 
79639 Grenzach-Wyhlen 
Germany </p>
<p>For any information about this medicine, please contact the local representative of the Marketing 
Authorisation Holder: </p>
<p>Belgi /Belgique/Belgien 
N.V. Roche S.A. 
T l/Tel: +32 (0) 2 525 82 Lietuva 
UAB  Roche Lietuva<br />
Tel: +370 5 2546  </p>
<p>: +359 2 818 44 Luxembourg/Luxemburg 
(Voir/siehe Belgique/Belgien) </p>
<p>esk  republika 
Roche s. r. o. 
Tel: +420 - 2 20382Magyarorsz g 
Roche (Magyarorsz g) Kft. 
Tel: +36   1 279 4Danmark 
Roche Pharmaceuticals A/S 
Tlf: +45 - 36 39 99 Malta 
(See Ireland) </p>
<p>Deutschland 
Roche Pharma AG 
Tel: +49 (0) 7624 Nederland 
Roche Nederland B.V. 
Tel: +31 (0) 348 438Eesti 
Roche Eesti O<br />
Tel: + 372 - 6 177 Norge 
Roche Norge AS 
Tlf: +47 - 22 78 90 <br />
Roche (Hellas) A.E.<br />
 : +30 210 61 66  sterreich 
Roche Austria GmbH 
Tel: +43 (0) 1 27Espa a 
Roche Farma S.A. 
Tel: +34 - 91 324 81 Polska 
Roche Polska Sp.z o.o. 
Tel: +48 - 22 345 18 France 
Roche 
T l: +33  (0)1 47 61 40 Portugal 
Roche Farmac utica Qu mica, Lda 
Tel: +351 - 21 425 70 Hrvatska 
Roche d.o.o. 
Tel: + 385 1 47 22 Rom nia 
Roche Rom nia S.R.L. 
Tel: +40 21 206 47 Ireland 
Roche Products (Ireland) Ltd. 
Tel: +353 (0) 1 469 0Slovenija 
Roche farmacevtska dru ba d.o.o. 
Tel: +386 - 1 360 26  sland<br />
Roche Pharmaceuticals A/S 
c/o Icepharma hf 
S mi: +354 540 8Slovensk  republika<br />
Roche Slovensko, s.r.o. 
Tel: +421 - 2 52638Italia 
Roche S.p.A. 
Tel: +39 - 039 2Suomi/Finland 
Roche Oy<br />
Puh/Tel: +358 (0) 10 554 K <br />
 . .  &amp;    . 
 : +357 - 22 76 62 Sverige 
Roche AB 
Tel: +46 (0) 8 726 1Latvija 
Roche Latvija SIA 
Tel: +371 - 6 7039United Kingdom (Northern Ireland) 
Roche Products (Ireland) Ltd. 
Tel: +44 (0) 1707 366This leaflet was last revised in  </p>
<p>Other sources of information </p>
<p>Detailed information on this medicine is available on the European Medicines Agency web site: </p>         </div>"""      

